Lilly buys rights to drug delivered through skin
Eli Lilly and Co. will pay $35 million for rights to an osteoporosis medicine delivered through the skin, the Indianapolis drugmaker announced today. Lilly has signed a licensing and development agreement with Israel-based TransPharma Medical Ltd. for exclusive rights to its ViaDerm-hPTH product and non-exclusive rights to its drug-delivery system, which delivers medicine through a […]